{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:50:17Z","timestamp":1788346217887,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.hlc.2026.01.007","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:18:24Z","timestamp":1776683904000},"page":"620-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["10-Year Trends in Lipoprotein(a) Testing in Queensland and Australia: A Retrospective Analysis of Ordering Patterns"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0510-7264","authenticated-orcid":false,"given":"Caroline A.E.","family":"Bachmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Arnott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0994-3588","authenticated-orcid":false,"given":"Andrew J.","family":"Kassianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam M.","family":"Kostner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2026.01.007_bib1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jacl.2019.04.010","article-title":"Use of lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association","volume":"13","author":"Wilson","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.hlc.2026.01.007_bib2","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hlc.2026.01.007_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"404","author":"Nordestgaard","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2026.01.007_bib4","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.hlc.2026.01.007_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0129","article-title":"Association of long-term exposure to elevated lipoprotein(a) levels with parental life span, chronic disease\u2013free survival, and mortality risk: a Mendelian randomization analysis","volume":"3","author":"Arsenault","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hlc.2026.01.007_bib6","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.116.026103","article-title":"A replicated, genome-wide significant association of aortic stenosis with a genetic variant for lipoprotein(a): meta-analysis of published and novel data","volume":"135","author":"Cairns","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2026.01.007_bib7","first-page":"143","article-title":"Lipoprotein (a) and risk of cardiovascular disease--a systematic review and meta analysis of prospective studies","volume":"57","author":"Genser","year":"2011","journal-title":"Clin Lab"},{"key":"10.1016\/j.hlc.2026.01.007_bib8","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2026.01.007_bib9","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.01.007_bib10","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1093\/eurheartj\/ehad547","article-title":"Significance of lipids, lipoproteins, and apolipoproteins during the first 14\u201316 months of life","volume":"44","author":"Taageby Nielsen","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2026.01.007_bib11","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.109.913673","article-title":"Impact of thrombophilia on risk of arterial ischemic stroke or cerebral Sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies","volume":"121","author":"Kenet","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2026.01.007_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1210\/clinem\/dgab734","article-title":"Lipoprotein(a) levels at birth and in early childhood: the COMPARE study","volume":"107","author":"Strandkj\u00e6r","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2026.01.007_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2022.03.004","article-title":"Lipoprotein(a) levels from childhood to adulthood: data in nearly 3,000 children who visited a pediatric lipid clinic","volume":"349","author":"de Boer","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hlc.2026.01.007_bib14","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2026.01.007_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2026.01.007_bib16","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hlc.2026.01.007_bib17","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","volume":"18","author":"Koschinsky","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.hlc.2026.01.007_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.hlc.2022.11.015","article-title":"Australian Atherosclerosis Society position statement on lipoprotein(a): clinical and implementation recommendations","volume":"32","author":"Ward","year":"2023","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2026.01.007_bib19","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.hlc.2020.03.005","article-title":"The prevalence of elevated lipoprotein(a) in patients presenting with coronary artery disease","volume":"29","author":"Oo","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2026.01.007_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0140-6736(88)92884-X","article-title":"Lipoprotein (a) and coronary heart disease in familial hypercholesterolaemia","volume":"2","author":"Houlston","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2026.01.007_bib21","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199005243222104","article-title":"Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia","volume":"322","author":"Seed","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.01.007_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jacl.2023.09.009","article-title":"Frequency of lipoprotein(a) measurements in patients with or at risk of cardiovascular disease","volume":"17","author":"Upadhyaya","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.hlc.2026.01.007_bib23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jacl.2023.09.016","article-title":"Prevalence of lipoprotein(a) measurement in patients with or at risk of cardiovascular disease","volume":"17","author":"Panza","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.hlc.2026.01.007_bib24","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1093\/eurjpc\/zwae155","article-title":"Trends and disparities in lipoprotein(a) testing in a large integrated US health system, 2000\u201323","volume":"31","author":"Faaborg-Andersen","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.hlc.2026.01.007_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100872","article-title":"Temporal trends in lipoprotein(a) testing among United States veterans from 2014 to 2023","volume":"20","author":"Gomez","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.hlc.2026.01.007_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjcard.2021.05.018","article-title":"Lipoprotein(a) testing patterns in a large health system","volume":"153","author":"Kelsey","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2026.01.007_bib27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jacl.2017.04.006","article-title":"Trends in testing for lipoprotein(a) at an Academic Medical Center over 13 years","volume":"11","author":"Wilkinson","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.hlc.2026.01.007_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1439013","article-title":"Trends and findings of lipoprotein(a) testing and associated cardiovascular disease profiles: a large single-center study from the Middle East-Gulf region","volume":"11","author":"Manla","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hlc.2026.01.007_bib29","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1093\/eurjpc\/zwac124","article-title":"Lipoprotein(a) testing in clinical practice: real-life data from a large healthcare provider","volume":"29","author":"Zafrir","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.hlc.2026.01.007_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.atherosclerosis.2022.01.022","article-title":"Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis","volume":"349","author":"Bhatia","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hlc.2026.01.007_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100478","article-title":"Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes","volume":"14","author":"Kelsey","year":"2023","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.hlc.2026.01.007_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031255","article-title":"Lipoprotein(a) testing trends in a Large Academic Health System in The United States","volume":"12","author":"Bhatia","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2026.01.007_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2023.01.014","article-title":"Trends and consequences of lipoprotein(a) testing: cross-sectional and longitudinal health insurance claims database analyses","volume":"367","author":"St\u00fcrzebecher","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hlc.2026.01.007_bib34","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.hlc.2024.01.042","article-title":"Time trends and missed opportunities in lipoprotein(a) testing amongst young patients with ST-elevation myocardial infarction in Western Australia","volume":"33","author":"Kelly","year":"2024","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2026.01.007_bib35","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1080\/0144929X.2023.2260889","article-title":"Choropleth maps can convey absolute magnitude through the range of the accompanying colour legend","volume":"43","author":"Bradley","year":"2024","journal-title":"Behav Inf Technol"},{"key":"10.1016\/j.hlc.2026.01.007_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1467-8306.1971.tb00779.x","article-title":"Error on choroplethic maps: definition, measurement, reduction","volume":"61","author":"Jenks","year":"1971","journal-title":"Ann Am Assoc Geogr"},{"key":"10.1016\/j.hlc.2026.01.007_bib39","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease","volume":"387","author":"O\u2019Donoghue","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.01.007_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.01.007_bib41","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2022.5050","article-title":"Single ascending dose study of a short interfering RNA targeting lipoprotein(a) production in individuals with elevated plasma lipoprotein(a) levels","volume":"327","author":"Nissen","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2026.01.007_bib42","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1001\/jama.2023.21835","article-title":"Lepodisiran, an extended-duration short interfering RNA targeting lipoprotein(a): a randomized dose-ascending clinical trial","volume":"330","author":"Nissen","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2026.01.007_bib43","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.2023.16503","article-title":"Muvalaplin, an oral small molecule inhibitor of lipoprotein(a) formation: a randomized clinical trial","volume":"330","author":"Nicholls","year":"2023","journal-title":"JAMA"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144395062600051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144395062600051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:45:18Z","timestamp":1778204718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S144395062600051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S144395062600051X"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2026.01.007","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"10-Year Trends in Lipoprotein(a) Testing in Queensland and Australia: A Retrospective Analysis of Ordering Patterns","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2026.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}